Health
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease – The Conversation UK
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…
Continue Reading
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Noosa News21 hours agoCloud Control celebrate 15 years of debut album Bliss Release with reunion tour